NCT00864318 2026-04-14
TICE
Institut Claudius Regaud
Phase 2 Completed
Clinical Trials
8 trialsNCT07423078 2026-04-13
WOLF
University of Pittsburgh
Phase 2 Recruiting
NCT05533775 2026-04-03
iMATRIX GLO
Hoffmann-La Roche
Phase 1/2 Recruiting
NCT05815160 2026-03-30
Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy
Debiopharm International SA
Phase 1 Active not recruiting
NCT06052839 2026-02-09
Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC
University of Pittsburgh
Phase 2 Recruiting
NCT02341989 2025-12-02
SWENOTECA-ABC
St. Olavs Hospital
Phase 3 Active not recruiting
NCT03981796 2025-09-03
RUBY
Tesaro, Inc.
Phase 3 Active not recruiting
NCT06859775 2025-06-06
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2 Recruiting